Global X China Innovator Active ETF

3058 HKD

Important Information

Investors should not base investment decisions on this website alone. Please refer to the Prospectus for details including the product features and the risk factors. Investment involves risks. There is no guarantee of the repayment of the principal. Investors should note:

  • Global X China Innovator Active ETF’s (the “Fund’s”) investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors, such as changes in investment sentiment, political and economic conditions and issuer-specific factors.
  • The Fund employs an actively managed investment strategy. The Fund does not seek to track any index or benchmark, and there is no replication or representative sampling conducted by the Manager. It may fail to meet its objective as a result of the Manager’s selection of investments, and/or the implementation of processes which may cause the Fund to underperform as compared to other index tracking funds with a similar objective.
  • Due to the concentration of the Fund’s investments in companies involved in Innovative Business, which are characterised by relatively higher volatility in price performance when compared to other economic sectors, the performance of the Fund may be more volatile than that of a fund having a more diverse portfolio of investments. In addition, the performance of the Fund may be exposed to risks associated with different sectors and themes, including industrial, consumer discretionary, healthcare, financials, information technology, robotics and artificial intelligence as well as technology (such as internet, fintech, cloud, e-commerce and digital). Fluctuations in the business for companies in these sectors or themes will have an adverse impact on the net asset value of the Fund.
  • China is an emerging market. The Fund invests in Chinese companies which may involve increased risks and special considerations not typically associated with investments in more developed markets, such as liquidity risk, currency risks, political risk, legal and taxation risks, and the likelihood of a high degree of volatility.
  • The trading price of the Unit on the SEHK is driven by market factors such as demand and supply of the Unit. Therefore, the Units may be traded at a substantial premium or discount to the Fund’s net asset value.

Fund Objective

The Fund is to achieve long term capital growth by primarily investing in companies which are headquartered or incorporated in the Mainland China, Hong Kong or Macau and are directly or indirectly involved in the provision of innovative products and/or services (“Innovative Business”). There can be no assurance that the Fund will achieve its investment objective.

Why Invest ?

High Growth Potential

Global X China Innovator Active ETF enables investors to access high growth potential through companies at the leading edge of multiple disruptive themes reshaping China.

Experienced Investment Team

The fund’s investment team has extensive track records in actively-managed equity strategies targeting China and the disruptive innovations tied to its economy.

ETF Efficiency

In a single trade, the fund delivers access to dozens of innovative companies across a range of disruptive themes, along with the outperformance potential of active management.

Near Real Time Estimated NAV per Share 1

-- $ --
-- $ --

Daily NAV per Share3As of 15 Oct 2021

NAV Change % Change
Official NAV per Share in RMB $46.43 $0.99 2.18%
NAV per Share in HKD6 $56.16 $1.20 2.18%

Performance As of 15 Oct 2021

Returns Fund
1Mo 1.87%
3Mo -14.35%
6Mo -7.66%
1Yr -
YTD -7.13%
Since Inception -7.13%
Past Performance Fund
2020 -
2019 -
2018 -
2017 -
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -
2010 -

Source: Mirae Asset Global Investments (Hong Kong) Limited.
• Past performance information is not indicative of future performance. Investors may not get back the full amount invested.
• The computation basis of the performance is based on the calendar year end, NAV-to-NAV, with dividend reinvested.
• These figures show by how much the Fund increased or decreased in value during the calendar year shown.
• Performance data has been calculated in RMB including ongoing charges and excluding trading costs on SEHK you might have to pay.
• Where no past performance is shown there was insufficient data available in that year to provide performance.
• The Fund launch date : 10 Mar 2021.

Fund Details As of 15 Oct 2021

Fund Information

Fund Inception Date 10 Mar 2021
SEHK Listing Date 11 Mar 2021
Fiscal Year Ending 31 Mar
Ongoing Charges Over A Year 7 0.75%
Management Fee 7 0.75%
Distribution Frequency Annually (usually in May of each year) at the Manager’s discretion.

Trading Information

Exchange Hong Kong Stock Exchange
Stock Code 3058
ISIN HK0000716099
Board Lot Size 50 Units
Trading Currency HKD
Total Net Asset Value $185,336,900.35
Oustanding Units 3,300,000
Stock Code
Board Lot Size
Trading Currency
Total Net Asset Value $153,234,311.99
Oustanding Units 3,300,000

Fund Documents

Key Documents

Monthly Returns

    Announcements / Notices

  • 28 Sep 2021 - Notice to Unitholders – Appointment of ABN AMRO Clearing Hong Kong Limited as Participating Dealer 
  • 10 Jun 2021 - Notice to Shareholders – Cessation AP Capital Management (Hong Kong) Limited to act as Market Maker 

Market Makers4

  • Flow Traders Hong Kong Limited
  • Mirae Asset Securities (HK) Limited

Participating dealers 5

  • Haitong International Securities Company Limited
  • Mirae Asset Securities (HK) Limited
  • ABN AMRO Clearing Hong Kong Limited

Holdings Overview

As of 15 Oct 2021
Total Net Asset Value (in HKD) Number of Securities Securities (%) Cash and Cash Equivalent (%)
$185,336,900.35 45 92.32 7.68

Daily Holdings

As of 15 Oct 2021
Name of Securities Exchange Ticker Exchange Market Price (in RMB) Number of Shares Held Market Value (in RMB) Net Assets %
TENCENT HOLDINGS LTD TENCENT HOLDINGS LTD 700 HK Hong Kong $409.76 25,200 $10,325,839.48 6.74%
ALIBABA GROUP HOLDING LTD 9988 HK Hong Kong $133.77 58,800 $7,865,917.27 5.13%
PING AN HEALTHCARE AND TECHN 1833 HK Hong Kong $42.87 137,300 $5,885,899.32 3.84%
INNOVENT BIOLOGICS INC 1801 HK Hong Kong $63.46 83,000 $5,266,838.57 3.44%
HAN'S LASER TECHNOLOGY IN 002008 C2 Shenzhen $39.13 134,500 $5,262,985.00 3.43%
SANGFOR TECHNOLOGIES INC 300454 C2 Shenzhen $241.88 21,400 $5,176,232.00 3.38%
MEITUAN-CLASS B 3690 HK Hong Kong $232.16 19,500 $4,527,153.77 2.95%
LONGI GREEN ENERGY TECHNOL 601012 C1 Shanghai $85.00 52,360 $4,450,600.00 2.90%
HUA HONG SEMICONDUCTOR LTD 1347 HK Hong Kong $32.04 135,000 $4,325,128.41 2.82%
NARI TECHNOLOGY DEVELOPMEN 600406 C1 Shanghai $34.34 123,300 $4,234,122.00 2.76%
CONTEMPORARY AMPEREX TECHN 300750 C2 Shenzhen $569.00 6,714 $3,820,266.00 2.49%
WUXI APPTEC CO LTD 2359 HK Hong Kong $136.01 27,320 $3,715,695.60 2.42%
EAST MONEY INFORMATION CO 300059 C2 Shenzhen $33.87 109,200 $3,698,604.00 2.41%
LUXSHARE PRECISION INDUSTR 002475 C2 Shenzhen $36.18 99,800 $3,610,764.00 2.36%
S F HOLDING CO LTD 002352 C2 Shenzhen $65.40 54,100 $3,538,140.00 2.31%
SINO BIOPHARMACEUTICAL 1177 HK Hong Kong $4.97 659,000 $3,274,563.51 2.14%
GOERTEK INC 002241 C2 Shenzhen $40.29 78,700 $3,170,823.00 2.07%
IFLYTEK CO LTD 002230 C2 Shenzhen $54.97 57,400 $3,155,278.00 2.06%
NETEASE INC 9999 HK Hong Kong $123.44 22,900 $2,826,759.24 1.84%
WUXI LEAD INTELLIGENT EQUI 300450 C2 Shenzhen $76.40 36,660 $2,800,824.00 1.83%
SHENZHEN MINDRAY BIO-MEDIC 300760 C2 Shenzhen $378.03 7,300 $2,759,619.00 1.80%
ESTUN AUTOMATION CO LTD 002747 C2 Shenzhen $24.64 110,600 $2,725,184.00 1.78%
BYD CO LTD 1211 HK Hong Kong $225.71 12,000 $2,708,553.54 1.77%
WILL SEMICONDUCTER LTD 603501 C1 Shanghai $250.00 10,198 $2,549,500.00 1.66%
BILIBILI INC-SPONSORED ADR BILI US NASDAQ GS $450.73 5,618 $2,532,222.22 1.65%
XIAOMI CORP-CLASS B 1810 HK Hong Kong $17.57 143,800 $2,526,453.75 1.65%
JIANGSU HENGRUI MEDICINE C 600276 C1 Shanghai $50.05 50,300 $2,517,515.00 1.64%
WUXI BIOLOGICS CAYMAN INC 2269 HK Hong Kong $90.45 26,500 $2,396,937.59 1.56%
ZTO EXPRESS CAYMAN INC-ADR ZTO US New York $200.96 11,145 $2,239,722.00 1.46%
HANGZHOU TIGERMED CONSULTI 300347 C2 Shenzhen $166.70 13,200 $2,200,440.00 1.44%
SHENZHEN INOVANCE TECHNOLO 300124 C2 Shenzhen $62.85 34,850 $2,190,322.50 1.43%
XINYI SOLAR HLDGS 968 HK Hong Kong $13.15 162,000 $2,129,637.42 1.39%
FUYAO GLASS INDUSTRY GROUP 3606 HK Hong Kong $36.71 57,600 $2,114,457.62 1.38%
NAVINFO CO LTD 002405 C2 Shenzhen $11.83 172,400 $2,039,492.00 1.33%
MIDEA GROUP CO LTD 000333 C2 Shenzhen $71.00 26,400 $1,874,400.00 1.22%
GUANGZHOU KDT MACHINERY CO 002833 C2 Shenzhen $31.52 58,200 $1,834,464.00 1.20%
YONYOU SOFTWARE CO LTD 600588 C1 Shanghai $33.97 52,000 $1,766,440.00 1.15%
LUFAX HOLDING LTD LU US New York $42.64 39,201 $1,671,378.05 1.09%
TONGWEI CO LTD 600438 C1 Shanghai $55.90 28,400 $1,587,560.00 1.04%
SMOORE INTERNATIONAL HOLDING 6969 HK Hong Kong $30.67 51,000 $1,564,363.29 1.02%
KINGDEE INTERNATIONAL SFTWR 268 HK Hong Kong $22.12 69,000 $1,526,041.72 1.00%
EVE ENERGY CO LTD 300014 C2 Shenzhen $108.15 13,900 $1,503,285.00 0.98%
BOE TECHNOLOGY GROUP CO LT 000725 C2 Shenzhen $5.13 263,900 $1,353,807.00 0.88%
RIYUE HEAVY INDUSTRY CO LT 603218 C1 Shanghai $34.28 32,500 $1,114,100.00 0.73%
FUTU HOLDINGS LTD-ADR FUTU US NASDAQ GM $409.83 2,718 $1,113,928.70 0.73%
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.
Back to Top

You’re now leaving Global X Hong Kong website

Clicking "Confirm" below will take you to an independent site. Information and services provided on this independent site are not reviewed by, guaranteed by, or Global X Hong Kong. This independent site's terms and conditions, privacy and security policies, or other legal information may be different from those of Global X Hong Kong’s site. Global X Hong Kong is not liable for any direct or indirect technical or system issues, consequences, or damages arising from your use of this independent website.


This website is intended for Hong Kong investors only. Your use of this website means you agree to our Terms of use. This website is strictly for informational purposes only and does not constitute a representation that any investment strategy is suitable or appropriate for an investor’s individual circumstances. In 2018, Global X was acquired by Mirae Asset Global Investments and Mirae Asset Global Investments Co., Ltd. is the parent company of Mirae Asset Global Investments (Hong Kong) Limited.

The information contained in this website is for information purposes only and does not, constitute any recommendations, offer or solicitation to buy, sell or subscribe to any securities or financial instruments in any jurisdiction. Investment involves risk. It cannot be guaranteed that the performance of the Product will generate a return and there may be circumstances where no return is generated or the amount invested is lost. Past performance is not indicative of future performance.

Before making any investment decision to invest in the Product, investors should read the Product’s prospectus for details and the risk factors. Investors should ensure they fully understand the risks associated with the Product and should also consider their own investment objective and risk tolerance level. Investors are advised to seek independent professional advice before making any investments.

Certain information contained in this website is compiled from third party sources. Whilst Mirae Asset Global Investments (Hong Kong) Limited (“Mirae Asset HK”), the Manager of the Product, has, to the best of its endeavor, ensured that such, information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information. Mirae Asset HK accepts no liability for, any loss or damage of any kind resulting out of the unauthorized use of this website.

The Products are not sponsored, endorsed, issued, sold or promoted by their index providers. For details of an index provider including any disclaimer, please refer to the relevant Product’s offering documents.

The contents of this website is prepared and maintained by Mirae Asset Global Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.